Data as of Sep 26, 2026 · Based on 4,029,442 AI responses across 13,338 prompts · See how Parse measures this
ICON plc is a global contract research organization delivering end-to-end clinical development and related services—from early clinical and bioanalytical work to manufacturing, regulatory affairs, and commercial consulting—across multiple therapeutic areas and industry sectors. They offer blended, technology-enabled solutions, including AI-powered platforms such as Orbis and EngageAI, to connect expertise, data, and insights across the trial lifecycle, plus specialties like cardiac safety, site and patient solutions, and real-world data. ICON serves biotech, pharmaceuticals, medical devices, government/public health and other clients, aiming to reduce time to market, maintain quality, and improve R&D ROI through integrated capabilities and global reach.
The market map · 5 of 100 labelled
Clinical Trial Management Software →Where ICON plc ranks in AI
No contexts measured yet.
Excerpts where ICON plc appeared in the AI's answer
ICON plc — Has a significant international infrastructure capable of managing large, complex, late-stage global and regional oncology trials in the CEE region.
ICON plc — Strengthened significantly in the region following strategic acquisitions (such as KCR)
Excerpts where ICON plc appeared in the AI's answer
ICON plc — Strong operational execution and broad therapeutic expertise, particularly for multinational studies.
Excerpts where ICON plc appeared in the AI's answer
ICON plc — A major global CRO with specialized dedicated capabilities in rare and orphan diseases.
ICON plc - A global clinical research provider with deep orphan drug and rare disease capabilities